Principal Investigators

Mary L. (Nora) Disis, M.D.

Dr. Disis is a Professor of Medicine and Adjunct Professor of Pathology and Obstetrics and Gynecology at the University of Washington (UW), and a Member of the Fred Hutchinson Cancer Research Center (FHCRC). She is the Associate Dean for Translational Science in the UW School of Medicine. Dr. Disis received her M.D. from the University of Nebraska Medical School and completed a residency and chief residency in Internal Medicine at the University of Illinois in Chicago. Her fellowship in oncology was done at UW/FHCRC. Dr. Disis is an expert in breast and ovarian cancer immunology and translational research. She is one of the pioneering investigators who discovered that HER-2/neu is a tumor antigen. Her work has led to several clinical trials which evaluate boosting immunity to HER-2/neu with cancer vaccines. Dr. Disis is a member of Alpha Omega Alpha and the American Society of Clinical Investigation. She is the Deputy Editor for Translational Oncology for the Journal of Clinical Oncology, and is a member of several committees and task forces for both the American Society of Clinical Oncology (ASCO) and the American Association for Cancer Research (AACR). She is also the Director of the Institute of Translational Health Sciences and the Director for the Center of Translational Medicine in Women’s Health at the UW. Her multifaceted research program within the Tumor Vaccine Group includes the discovery of new antigens for breast and ovarian cancer and the development of vaccine and cellular therapy targeting those antigens.
DONE
MORE >

Lupe Salazar, M.D.

Dr. Salazar, M.D. is an Assistant Professor of Medicine at the UW and a member of the Fred Hutchinson Cancer Research Center (FHCRC) Breast Cancer and Gynecologic Cancer Program. Dr. Salazar completed medical school and Internal Medicine residency training at the University of Minnesota, and completed her fellowship training in Hematology / Oncology at the UW. Dr. Salazar is the past recipient of a Hugh J. Anderson Memorial Scholarship, Bristol-Meyers Squibb National Medical Fellowship, and currently holds a Mentored Clinical Scientist Award (K23) from the NCI. Dr. Salazar's research focuses on the development of novel Phase I and II studies of immunotherapy. These studies include testing novel cancer vaccines for the treatment and/or prevention of solid tumors. Of particular interest to Dr. Salazar is assessing the development of immunologic memory as the endpoint of a successful cancer vaccine. In addition, she is evaluating how to enhance endogenous tumor immunity by modulating the activity of immunoregulatory cells.
DONE
MORE >

Hailing Lu, Ph.D.

Dr. Lu is an Acting Assistant Professor of Oncology at the UW. Dr. Lu received her Ph.D. in Toxicology from the UW in 2001. She had post-doctoral training at the Fred Hutchinson Cancer Research Center studying the effect of interleukin-7 on immune reconstitution before she joined the Tumor Vaccine Group. Dr. Lu is working on the development of multi-antigen vaccines to prevent breast cancer.

Ron E. Swensen, M.D.

Dr. Swensen is an Associate Professor in the Department of Obstetrics and Gynecology at the UW. He received his M.D. in 1984 from Loma Linda University, California, and completed his internship in 1985 at University of Wisconsin Hospitals in Madison, Wisconsin. His residency was completed in 1988 at Stanford University Hospital in Obstetrics and Gynecology and he was selected as Outstanding Resident Instructor in 1985 – 1986. He completed a fellowship in gynecologic oncology in 1995 at Hershey Medical Center in Hershey, Pennsylvania. From 1990 to 2003, Dr. Swensen was an Assistant Professor in the Loma Linda University School of Medicine, and he is the former Chief, Gynecology Division at Jerry L. Pettis Memorial Veterans Hospital.
DONE
MORE >

Heidi Gray, M.D.

Dr. Gray is an Assistant Professor in the Department of Obstetrics and Gynecology at the UW. She received her M.D. from the University of California, San Diego in 1997, and completed her Obstetrics and Gynecology residency training at the UW. She completed her fellowship in Gynecologic Oncology at the Hospital of the University of Pennsylvania. Concurrently, she was an instructor for the Department of Obstetrics and Gynecology at the University of Pennsylvania. In 1999, Dr. Gray received the Berlex Award for Best Teaching Second Year Resident at UW, as well as the Gallway Fellowship in Gynecologic Oncology at Memorial-Sloan Kettering Cancer Center. In 2001, she received the David C. Figge Award for Outstanding Chief Resident in Gynecologic Oncology, UW. She is presently conducting ovarian cancer research under a grant from the Gynecologic Cancer Foundation.
DONE
MORE >